Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine

Jong J. Kim, Neil N. Trivedi, Darren M. Wilson, Sundarasamy Mahalingam, Lake Morrison, Anthony Tsai, Michael Anand Chattergoon, Kesen Dang, Mamata Patel, Lois Ahn, Jean D. Boyer, Ara A. Chalian, Hubert Shoemaker, Thomas Kieber-Emmons, Michael A. Agadjanyan, David B. Weiner

Research output: Contribution to journalArticle

Abstract

Nucleic acid immunization has been investigated as immunotherapy for infectious diseases as well as for treating specific types of cancers. In this approach, nucleic acid expression cassettes are directly inoculated into the host, whose transfected cells become the production source of novel and possibly immunologically foreign protein. We have developed a DNA vaccine construct which encodes for PSA by cloning a cDNA for PSA into a mammalian expression vector under control of a CMV promoter. We investigated and characterized the immunogenicity of PSA DNA expression cassettes in mice. PSA-specific immune responses induced in vivo by immunization were characterized by enzyme-linked immunosorbent assay (ELISA), T helper proliferation cytotoxic T lymphocyte (CTL), and flow cytometry assays. We observed a strong and persistent antibody response against PSA for at least 180 days following immunization. In addition, a significant T helper cell proliferation was observed against PSA protein. Using synthetic peptides spanning the PSA open frame, we identified four dominant T helper epitopes of PSA. Furthermore, immunization with PSA plasmid induced MHC Class I CD8+ T cell-restricted cytotoxic T lymphocyte response against tumor cell targets expressing PSA. The prostate represents a very specific functional organ critical for reproduction but not for the health and survival of the individual. Understanding the immunogenicity of PSA DNA immunization cassettes offers insight into the possible use of this tumor-associated antigen as a target for immunotherapy. These results demonstrate the ability of the genetic PSA to serve as a specific immune target capable of generating both humoral and cellular immune responses in vitro.

Original languageEnglish (US)
Pages (from-to)3125-3135
Number of pages11
JournalOncogene
Volume17
Issue number24
StatePublished - Dec 17 1998
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Vaccines
Immunization
Cytotoxic T-Lymphocytes
Immunotherapy
Nucleic Acids
DNA Vaccines
DNA
Neoplasm Antigens
Humoral Immunity
Cellular Immunity
Antibody Formation
Reproduction
Communicable Diseases
Organism Cloning
Prostate
Epitopes
Neoplasms
Flow Cytometry
Proteins

Keywords

  • DNA vaccination
  • Epitope mapping
  • Immune responses
  • Immunotherapy
  • Prostate cancer
  • PSA

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Kim, J. J., Trivedi, N. N., Wilson, D. M., Mahalingam, S., Morrison, L., Tsai, A., ... Weiner, D. B. (1998). Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine. Oncogene, 17(24), 3125-3135.

Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine. / Kim, Jong J.; Trivedi, Neil N.; Wilson, Darren M.; Mahalingam, Sundarasamy; Morrison, Lake; Tsai, Anthony; Chattergoon, Michael Anand; Dang, Kesen; Patel, Mamata; Ahn, Lois; Boyer, Jean D.; Chalian, Ara A.; Shoemaker, Hubert; Kieber-Emmons, Thomas; Agadjanyan, Michael A.; Weiner, David B.

In: Oncogene, Vol. 17, No. 24, 17.12.1998, p. 3125-3135.

Research output: Contribution to journalArticle

Kim, JJ, Trivedi, NN, Wilson, DM, Mahalingam, S, Morrison, L, Tsai, A, Chattergoon, MA, Dang, K, Patel, M, Ahn, L, Boyer, JD, Chalian, AA, Shoemaker, H, Kieber-Emmons, T, Agadjanyan, MA & Weiner, DB 1998, 'Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine', Oncogene, vol. 17, no. 24, pp. 3125-3135.
Kim JJ, Trivedi NN, Wilson DM, Mahalingam S, Morrison L, Tsai A et al. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine. Oncogene. 1998 Dec 17;17(24):3125-3135.
Kim, Jong J. ; Trivedi, Neil N. ; Wilson, Darren M. ; Mahalingam, Sundarasamy ; Morrison, Lake ; Tsai, Anthony ; Chattergoon, Michael Anand ; Dang, Kesen ; Patel, Mamata ; Ahn, Lois ; Boyer, Jean D. ; Chalian, Ara A. ; Shoemaker, Hubert ; Kieber-Emmons, Thomas ; Agadjanyan, Michael A. ; Weiner, David B. / Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine. In: Oncogene. 1998 ; Vol. 17, No. 24. pp. 3125-3135.
@article{ae05ae0582c04e6ebecd1abb3509b62f,
title = "Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine",
abstract = "Nucleic acid immunization has been investigated as immunotherapy for infectious diseases as well as for treating specific types of cancers. In this approach, nucleic acid expression cassettes are directly inoculated into the host, whose transfected cells become the production source of novel and possibly immunologically foreign protein. We have developed a DNA vaccine construct which encodes for PSA by cloning a cDNA for PSA into a mammalian expression vector under control of a CMV promoter. We investigated and characterized the immunogenicity of PSA DNA expression cassettes in mice. PSA-specific immune responses induced in vivo by immunization were characterized by enzyme-linked immunosorbent assay (ELISA), T helper proliferation cytotoxic T lymphocyte (CTL), and flow cytometry assays. We observed a strong and persistent antibody response against PSA for at least 180 days following immunization. In addition, a significant T helper cell proliferation was observed against PSA protein. Using synthetic peptides spanning the PSA open frame, we identified four dominant T helper epitopes of PSA. Furthermore, immunization with PSA plasmid induced MHC Class I CD8+ T cell-restricted cytotoxic T lymphocyte response against tumor cell targets expressing PSA. The prostate represents a very specific functional organ critical for reproduction but not for the health and survival of the individual. Understanding the immunogenicity of PSA DNA immunization cassettes offers insight into the possible use of this tumor-associated antigen as a target for immunotherapy. These results demonstrate the ability of the genetic PSA to serve as a specific immune target capable of generating both humoral and cellular immune responses in vitro.",
keywords = "DNA vaccination, Epitope mapping, Immune responses, Immunotherapy, Prostate cancer, PSA",
author = "Kim, {Jong J.} and Trivedi, {Neil N.} and Wilson, {Darren M.} and Sundarasamy Mahalingam and Lake Morrison and Anthony Tsai and Chattergoon, {Michael Anand} and Kesen Dang and Mamata Patel and Lois Ahn and Boyer, {Jean D.} and Chalian, {Ara A.} and Hubert Shoemaker and Thomas Kieber-Emmons and Agadjanyan, {Michael A.} and Weiner, {David B.}",
year = "1998",
month = "12",
day = "17",
language = "English (US)",
volume = "17",
pages = "3125--3135",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "24",

}

TY - JOUR

T1 - Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine

AU - Kim, Jong J.

AU - Trivedi, Neil N.

AU - Wilson, Darren M.

AU - Mahalingam, Sundarasamy

AU - Morrison, Lake

AU - Tsai, Anthony

AU - Chattergoon, Michael Anand

AU - Dang, Kesen

AU - Patel, Mamata

AU - Ahn, Lois

AU - Boyer, Jean D.

AU - Chalian, Ara A.

AU - Shoemaker, Hubert

AU - Kieber-Emmons, Thomas

AU - Agadjanyan, Michael A.

AU - Weiner, David B.

PY - 1998/12/17

Y1 - 1998/12/17

N2 - Nucleic acid immunization has been investigated as immunotherapy for infectious diseases as well as for treating specific types of cancers. In this approach, nucleic acid expression cassettes are directly inoculated into the host, whose transfected cells become the production source of novel and possibly immunologically foreign protein. We have developed a DNA vaccine construct which encodes for PSA by cloning a cDNA for PSA into a mammalian expression vector under control of a CMV promoter. We investigated and characterized the immunogenicity of PSA DNA expression cassettes in mice. PSA-specific immune responses induced in vivo by immunization were characterized by enzyme-linked immunosorbent assay (ELISA), T helper proliferation cytotoxic T lymphocyte (CTL), and flow cytometry assays. We observed a strong and persistent antibody response against PSA for at least 180 days following immunization. In addition, a significant T helper cell proliferation was observed against PSA protein. Using synthetic peptides spanning the PSA open frame, we identified four dominant T helper epitopes of PSA. Furthermore, immunization with PSA plasmid induced MHC Class I CD8+ T cell-restricted cytotoxic T lymphocyte response against tumor cell targets expressing PSA. The prostate represents a very specific functional organ critical for reproduction but not for the health and survival of the individual. Understanding the immunogenicity of PSA DNA immunization cassettes offers insight into the possible use of this tumor-associated antigen as a target for immunotherapy. These results demonstrate the ability of the genetic PSA to serve as a specific immune target capable of generating both humoral and cellular immune responses in vitro.

AB - Nucleic acid immunization has been investigated as immunotherapy for infectious diseases as well as for treating specific types of cancers. In this approach, nucleic acid expression cassettes are directly inoculated into the host, whose transfected cells become the production source of novel and possibly immunologically foreign protein. We have developed a DNA vaccine construct which encodes for PSA by cloning a cDNA for PSA into a mammalian expression vector under control of a CMV promoter. We investigated and characterized the immunogenicity of PSA DNA expression cassettes in mice. PSA-specific immune responses induced in vivo by immunization were characterized by enzyme-linked immunosorbent assay (ELISA), T helper proliferation cytotoxic T lymphocyte (CTL), and flow cytometry assays. We observed a strong and persistent antibody response against PSA for at least 180 days following immunization. In addition, a significant T helper cell proliferation was observed against PSA protein. Using synthetic peptides spanning the PSA open frame, we identified four dominant T helper epitopes of PSA. Furthermore, immunization with PSA plasmid induced MHC Class I CD8+ T cell-restricted cytotoxic T lymphocyte response against tumor cell targets expressing PSA. The prostate represents a very specific functional organ critical for reproduction but not for the health and survival of the individual. Understanding the immunogenicity of PSA DNA immunization cassettes offers insight into the possible use of this tumor-associated antigen as a target for immunotherapy. These results demonstrate the ability of the genetic PSA to serve as a specific immune target capable of generating both humoral and cellular immune responses in vitro.

KW - DNA vaccination

KW - Epitope mapping

KW - Immune responses

KW - Immunotherapy

KW - Prostate cancer

KW - PSA

UR - http://www.scopus.com/inward/record.url?scp=0032542209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032542209&partnerID=8YFLogxK

M3 - Article

C2 - 9872328

AN - SCOPUS:0032542209

VL - 17

SP - 3125

EP - 3135

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 24

ER -